In a report released today, Suraj Kalia from Northland Securities maintained a Sell rating on Intuitive Surgical (ISRG), with a price target of $375. The company’s shares opened today at $533.25.
According to TipRanks.com, Kalia is a 5-star analyst with an average return of 11.1% and a 59.9% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Varex Imaging Corporation, and Strata Skin Sciences Inc.
Currently, the analyst consensus on Intuitive Surgical is a Moderate Buy with an average price target of $576.56.
See today’s analyst top recommended stocks >>
Based on Intuitive Surgical’s latest earnings release for the quarter ending March 31, the company reported a quarterly net profit of $307 million. In comparison, last year the company had a net profit of $255 million.
Based on the recent corporate insider activity of 75 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
